{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:25:38Z","timestamp":1788175538933,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,5,26]],"date-time":"2012-05-26T00:00:00Z","timestamp":1337990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s12185-012-1102-1","type":"journal-article","created":{"date-parts":[[2012,5,25]],"date-time":"2012-05-25T08:13:30Z","timestamp":1337933610000},"page":"58-64","source":"Crossref","is-referenced-by-count":8,"title":["High serum carbohydrate antigen-125 (CA-125) level predicts poor outcome in patients with follicular lymphoma independently of the FLIPI score"],"prefix":"10.1007","volume":"96","author":[{"given":"V\u00edt","family":"Proch\u00e1zka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Faber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lud\u011bk","family":"Raida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Kapit\u00e1\u0148ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate\u0159ina","family":"Langov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Indr\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Papaj\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,26]]},"reference":[{"key":"1102_CR1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","volume":"107","author":"LM Morton","year":"2006","unstructured":"Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001. Blood. 2006;107:265\u201376.","journal-title":"Blood"},{"key":"1102_CR2","unstructured":"Trn\u011bn\u00fd M, V\u00e1\u0161ov\u00e1 I, Pytl\u00edk R, Belada D, Jankovsk\u00e1 M, Kub\u00e1\u010dkov\u00e1 K et al. The non-Hodgkin\u2019s lymphoma subtypes distribution and survival in Czech Republic. Klinicka onkologie 2007;20:341\u20138."},{"key":"1102_CR3","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1200\/JCO.2005.04.503","volume":"23","author":"WT Swenson","year":"2005","unstructured":"Swenson WT, Wooldridge JE, Lynch CF, Forman-Hoffman VL, Chrischilles E, Link BK. Improved survival of follicular lymphoma patients in the United States. J Clin Oncol. 2005;23:5019\u201326.","journal-title":"J Clin Oncol"},{"key":"1102_CR4","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"P Solal-Celigny","year":"2004","unstructured":"Solal-Celigny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, et al. Follicular lymphoma international prognostic index. Blood. 2004;104:1258\u201365.","journal-title":"Blood"},{"key":"1102_CR5","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/annonc\/mdp053","volume":"20","author":"SA Schans van de","year":"2009","unstructured":"van de Schans SA, Steyerberg EW, Nijziel MR, Creemers GJ, Janssen-Heijnen ML, van Spronsen DJ. Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting. Ann Oncol. 2009;20:1697\u2013702.","journal-title":"Ann Oncol"},{"key":"1102_CR6","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood-2006-01-013367","volume":"108","author":"C Buske","year":"2006","unstructured":"Buske C, Hoster E, Dreyling M, Hasford J, Unterhalt M, Hiddemann W. The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) with respect to treatment outcome. Blood. 2006;108:1504\u20138.","journal-title":"Blood"},{"key":"1102_CR7","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/annonc\/mdh406","volume":"15","author":"S Montoto","year":"2004","unstructured":"Montoto S, L\u00f3pez-Guillermo A, Alt\u00e9s A, Perea G, Ferrer A, Cam\u00f3s M, et al. Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression. Ann Oncol. 2004;15:1484\u20139.","journal-title":"Ann Oncol"},{"key":"1102_CR8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00004347-198303000-00005","volume":"2","author":"SE Kabawat","year":"1983","unstructured":"Kabawat SE, Bast RC Jr, Bhan AK, Welch WR, Knapp RC, Colvin RB. Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125. Int J Gynecol Pathol. 1983;2:275\u201385.","journal-title":"Int J Gynecol Pathol"},{"key":"1102_CR9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJM198310133091503","volume":"309","author":"RC Bast","year":"1983","unstructured":"Bast RC, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983;309:883\u20137.","journal-title":"N Engl J Med"},{"key":"1102_CR10","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1158\/1940-6207.CAPR-11-0378","volume":"4","author":"O Dorigo","year":"2011","unstructured":"Dorigo O, Berek JS. Personalizing CA125 levels for ovarian cancer screening. Cancer Prev Res (Phila). 2011;4:1356\u20139.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"2","key":"1102_CR11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s10120-011-0091-8","volume":"15","author":"S Emoto","year":"2012","unstructured":"Emoto S, Ishigami H, Yamashita H, Yamaguchi H, Kaisaki S, Kitayama J, et al. Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination. Gastric Cancer. 2012;15(2):154\u201361.","journal-title":"Gastric Cancer"},{"key":"1102_CR12","first-page":"527","volume":"6","author":"PH Wiernik","year":"2008","unstructured":"Wiernik PH. Serum CA125 and PSA concentrations in patients with lymphoma. Clin Adv Hematol Oncol. 2008;6:527\u201331.","journal-title":"Clin Adv Hematol Oncol"},{"key":"1102_CR13","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1023\/A:1026789232033","volume":"11","author":"L Benboubker","year":"2000","unstructured":"Benboubker L, Valat C, Linassier C, Cartron G, Delain M, Bout M, et al. A new serologic index for low-grade non-Hodgkin\u2019s lymphoma based on initial CA125 and LDH serum levels. Ann Oncol. 2000;11:1485\u201391.","journal-title":"Ann Oncol"},{"key":"1102_CR14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0936-6555(05)80119-0","volume":"6","author":"JM Rodriguez","year":"1994","unstructured":"Rodriguez JM. Elevated CA125 levels in association with Ki-1 anaplastic lymphoma. Clin Oncol (R Coll Radiol). 1994;6:137.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1102_CR15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1046\/j.1365-2141.1997.2383054.x","volume":"98","author":"I Kubonishi","year":"1997","unstructured":"Kubonishi I, Bandobashi K, Murata N, Daibata M, Ido E, Sonobe H, et al. High serum levels of CA125 and interleukin-6 in a patient with Ki-1 lymphoma. Br J Haematol. 1997;98:450\u20132.","journal-title":"Br J Haematol"},{"key":"1102_CR16","first-page":"209","volume":"21","author":"Abd El","year":"2009","unstructured":"El Abd, Gawad IA, Shafik HE. CA 125, a new prognostic marker for aggressive NHL. J Egypt Natl Canc Inst. 2009;21:209\u201317.","journal-title":"J Egypt Natl Canc Inst."},{"key":"1102_CR17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5301\/JBM.2009.3140","volume":"23","author":"W Gui","year":"2008","unstructured":"Gui W, Wang T, Wang J, Wang L, He J, Yang B, et al. An improved prognostic parameter for non-Hodgkin\u2019s lymphoma based on the combination of three serum tumor markers. Int J Biol Markers. 2008;23:207\u201313.","journal-title":"Int J Biol Markers"},{"key":"1102_CR18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1751-553X.2010.01225.x","volume":"32","author":"A Gutierrez","year":"2010","unstructured":"Gutierrez A, Martinez-Serra J, Barcelo B, Sampol A, Vi\u00f1as L, Gonz\u00e1lez G, et al. Prognostic value of serum CA125 levels in diffuse large B-cell lymphoma: potential role of a new sex- and age-adjusted reference value. Int J Lab Hematol. 2010;32:582\u20139.","journal-title":"Int J Lab Hematol"},{"key":"1102_CR19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1600-0609.2007.00843.x","volume":"78","author":"C Bonnet","year":"2007","unstructured":"Bonnet C, Beguin Y, Fassotte MF, Seidel L, Luyckx F, Fillet G. Limited usefulness of CA125 measurement in the management of Hodgkin\u2019s and non-Hodgkin\u2019s lymphoma. Eur J Haematol. 2007;78:399\u2013404.","journal-title":"Eur J Haematol"},{"key":"1102_CR20","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.3109\/10428194.2010.496881","volume":"51","author":"RP Ojha","year":"2010","unstructured":"Ojha RP, Brown LM, Felini MJ, Singh KP, Thertulien R. Addressing uncertainty regarding the utility of carbohydrate antigen-125 as a prognostic marker in non-Hodgkin lymphoma. Leuk Lymphoma. 2010;51:1754\u20137.","journal-title":"Leuk Lymphoma"},{"key":"1102_CR21","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1200\/JCO.1999.17.8.2499","volume":"17","author":"D Decaudin","year":"1999","unstructured":"Decaudin D, Lepage E, Brousse N, Brice P, Harousseau JL, Belhadj K, et al. Low-grade stage III\u2013IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients\u2014a study of the groupe d\u2019Etude des lymphomes de l\u2019Adulte. J Clin Oncol. 1999;17:2499\u2013505.","journal-title":"J Clin Oncol"},{"key":"1102_CR22","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","volume":"328","author":"RI Fisher","year":"1993","unstructured":"Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin\u2019s lymphoma. N Engl J Med. 1993;328:1002\u20136.","journal-title":"N Engl J Med"},{"key":"1102_CR23","first-page":"800","volume":"83","author":"M Federico","year":"1998","unstructured":"Federico M, Clo V, Brugiatelli M, Carotenuto M, Gobbi PG, Vallisa D, et al. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin\u2019s lymphoma. Final report of a multicenter trial conducted by GISL. Haematologica. 1998;83:800\u201311.","journal-title":"Haematologica"},{"key":"1102_CR24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5507\/bp.2009.011","volume":"153","author":"V Prochazka","year":"2009","unstructured":"Prochazka V, Faber E, Raida L, Vondrakova J, Kucerova L, Jarosova M, et al. Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009;153:63\u20136.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"1102_CR25","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/0277-5379(90)90180-2","volume":"26","author":"P Colombat","year":"1990","unstructured":"Colombat P, Biron P, Laporte JP, Cahn JY, Herve P, Gorin NC, et al. BEAM protocol and autologous bone marrow transplantation in first chemosensitive relapse of non-Hodgkin\u2019s lymphomas. Eur J Cancer. 1990;26:858.","journal-title":"Eur J Cancer"},{"key":"1102_CR26","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, et al. Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999;17:1244.","journal-title":"J Clin Oncol"},{"key":"1102_CR27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12185-010-0674-x","volume":"92","author":"P Solal-C\u00e9ligny","year":"2010","unstructured":"Solal-C\u00e9ligny P, Cahu X, Cartron G. Follicular lymphoma prognostic factors in the modern era: what is clinically meaningful? Int J Hematol. 2010;92:246\u201354.","journal-title":"Int J Hematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1102-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-012-1102-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-012-1102-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:01:46Z","timestamp":1559451706000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-012-1102-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,26]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["1102"],"URL":"https:\/\/doi.org\/10.1007\/s12185-012-1102-1","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,26]]}}}